FdaApplication
ANDA 219869
Identifiers
- fda_app_no: ANDA219869
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2026-05-27 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 25MG;100MG | TABLET;ORAL |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 12.5MG;50MG | TABLET;ORAL |
| LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 12.5MG;100MG | TABLET;ORAL |
3 products